We are live on ! Find out more
IRD

Opus Genetics
IRD

16 hedge funds and large institutions have $930K invested in Opus Genetics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.12% more ownership

Funds ownership: 0% → 1.12% (+1.1%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

43% less funds holding

Funds holding: 28 → 16 (-12)

48% less capital invested

Capital invested by funds: $1.78M → $930K (-$845K)

86% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 14

Holders
16
Holders Change
-12
Holders Change %
-42.86%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
14
Calls
$73K
Puts
–
Net Calls
+$73K
Net Calls Change
+$66K

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$196K
2
Bank of America
Bank of America
North Carolina
+$1.22K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$701
4
Morgan Stanley
Morgan Stanley
New York
+$678
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$497

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$454K
2
BlackRock
BlackRock
New York
-$59.6K
3
BCM
Bridgeway Capital Management
Texas
-$53K
4
Northern Trust
Northern Trust
Illinois
-$51K
5
TSS
Two Sigma Securities
New York
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$1 – –
RFM
27
Royal Fund Management
Florida
– +$23 +1 New
1
2

IRD Hedge Fund Activity: Q2 2019 in Review

16 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2019, worth a combined $930K — down 48% from $1.78M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of IRD and 2 opened new positions — a net loss of 12 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $196K. The largest seller was Vanguard Group, cutting an estimated $454K.

  • 16 institutional investors held Opus Genetics (IRD) as of Q2 2019, down from 28 in Q1 2019.
  • Funds reported $930K of Opus Genetics stock for Q2 2019, down 48% quarter-over-quarter.
  • 2 funds opened new Opus Genetics positions in Q2 2019 and 14 closed out, a net change of -12 holders.
  • The largest Opus Genetics buyer in Q2 2019 was Renaissance Technologies, an estimated $196K added.
  • The largest Opus Genetics seller in Q2 2019 was Vanguard Group, an estimated $454K sold.

Based on aggregated 13F filings for Q2 2019.